Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04044144 · ClinicalTrials.gov registry record · NA
Prospective Tolerability Assessment of a Probiotic Dietary Supplement
A NA study of Healthy Adults, sponsored by Metagenics.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04044144: Completed NA study of Healthy Adults, sponsored by Metagenics.
NCT04044144 is a NA study of Healthy Adults that has completed, run by Metagenics. The registered enrollment target is 10 participants, below the 86-participant average among 33 other Healthy Adults trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04044144, a NA study of Healthy Adults, has completed, sponsored by Metagenics.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The dietary supplement being investigated is a formula containing a combination of eight probiotic strains. The combination formula was developed to support general gastrointestinal and immune health. Each of the strains in the formula have previously been studied in human subjects, including several clinical populations. However, the present eight strain combination formula has not previously been evaluated in human subjects. This prospective study will evaluate the tolerability of the eight strain formula in healthy adults.
Primary Outcome
Tolerability of oral intake of the probiotic supplement will primarily be evaluated by determining the frequency of participants who withdraw from the study due to adverse events during the supplementation period
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Probiotic Dietary Supplement
Study Locations (1)
Washington
- Personalized Lifestyle Medicine Center - Gig Harbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-08-12 |
| Est. Completion | 2019-08-23 |
| Phase | NA |
What the finished NCT04044144 record still lists
NCT04044144 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 86-participant average among 33 other Healthy Adults trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Healthy Adults appearing as the primary indexed condition, and to 1 intervention - of which Probiotic Dietary Supplement is the first listed.
NCT04044144 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04044144 about?
NCT04044144 is a clinical study titled "Prospective Tolerability Assessment of a Probiotic Dietary Supplement". The dietary supplement being investigated is a formula containing a combination of eight probiotic strains. The combination formula was developed to support general gastrointestinal and immune health. Each of the strains in the formula have previously been studied in human subjects, including severa...
What is the current status of trial NCT04044144?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-08-12. Estimated completion is 2019-08-23.
What conditions does trial NCT04044144 study?
This clinical trial studies the following conditions: Healthy Adults.
What interventions are being tested in trial NCT04044144?
The interventions under investigation include: Probiotic Dietary Supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04044144?
This trial is sponsored by Metagenics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04044144 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adults
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04044144's enrollment target sits among peer trials
10 33rd of 33 higher than 1 of 33 other Healthy Adults trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Adults trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
RECRUITING · NA
-
Health Properties of Pecan Nut Consumption
RECRUITING · NA
-
The Brain Processes Underlying Speech Motor Learning and Speech Production
RECRUITING · NA
-
Effect of Acute Nitrate Supplementation on Vascular Function in Hispanic, Black and White Population
RECRUITING · NA
-
Pilot Study of the Entarik System With Advanced Functionality in Health Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI